During the past decade, Omega Research MetroWest, LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Omega Research MetroWest, LLC" are "SLE; Drug" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Omega Research MetroWest, LLC" in a lesser frequency.

Most popular intervention types in "Omega Research MetroWest, LLC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "KPG-818 high dose" (1 trials), "KPG-818 low dose" (1 trials), "KPG-818 mid dose" (1 trials) and "PF-06700841 15 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Omega Research MetroWest, LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Omega Research MetroWest, LLC". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Omega Research MetroWest, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Omega Research MetroWest, LLC, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".